TLPH

Insider Trades

Actor	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Aslam ShakilChief Medical Officer --4.5k shares Grant / ExerciseMay 20, 2026 $3.7K4.5k shares $0.824 $0.8216
Aslam ShakilInsider --4.5k shares OtherMay 20, 2026 $3.7K4.5k shares $0.824 $0.8216

News

seekingalpha.comTalphera, Inc. (TLPH) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 13

prnewswire.comTalphera Announces First Quarter 2026 Financial Results and Provides Corporate Updateprnewswire.comMay 13

prnewswire.comTalphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026prnewswire.comMay 7

prnewswire.comTalphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026prnewswire.comMar 25

defenseworld.netTalphera Q4 Earnings Call Highlightsdefenseworld.netMar 25

Trade TLPH

About Talphera, Inc.

Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimental candidate is Niyad, a lyophilized (freeze-dried) formulation of nafamostat. This anticoagulant is currently being assessed under an investigational device exemption for its application in extracorporeal circuits. The company's development pipeline also features LTX-608, a potential anti-inflammatory and antiviral agent being explored for the treatment of numerous conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis. Furthermore, Talphera is advancing Fedsyra, a pre-filled syringe containing ephedrine, and PFS-02, a pre-filled syringe containing phenylephrine. Established in 2005, the company was previously known as AcelRx Pharmaceuticals, Inc. It adopted the name Talphera, Inc. in January 2024 and maintains its corporate headquarters in San Mateo, California.

CEO: Vincent J. Angotti
IPO Date: Feb 11, 2011

Market Data

Open: $0.83
High: $0.859
Low: $0.792
Volume: 171K
52W High: $1.57
52W Low: $0.38

Valuation

Market Cap: $17M
Enterprise Value: $13M

Financials

Free Cash Flow: $-11M
Revenue: $28k
Net Income: $-14M
Cash: $5.9M
Debt: $6.5M

Events

EarningsAug 13

EPS est. -0.07